12:00 AM
 | 
Feb 07, 2000
 |  BC Week In Review  |  Company News  |  Deals

Alkermes, Glaxo Wellcome deal

GLXO received a license to ALKS's AIR pulmonary drug delivery technology for use in four respiratory...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >